Breztri Aerosphere (PT010) approved in Japan for
19 June 2019 07:00 BST Breztri Aerosphere (PT010) approved in Japan forpatients with chronic obstructive pulmonary disease First global approval and only triple-combination therapyin a pressurised metered-dose inhaler device in Japan AstraZeneca today announced that Breztri Aerosphere (budesonide/glycopyrronium/ formoterol fumarate), formerly PT010, has been approved in Japan as a triple-combination therapy to relieve symptoms of chronic obstructive pulmonary disease (COPD). This is the first global regulatory approval for Breztri Aerosphere and is the first approval by the